엑소좀 치료 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)

Exosome Therapeutics Trends and Forecast

The future of the global exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets. The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030 with a CAGR of 25.7% from 2024 to 2030. The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

A more than 150-page report is developed to help in your business decisions.

Exosome Therapeutics by Segment

The study includes a forecast for the global exosome therapeutics by type, application, end use, and region.

Exosome Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Natural Exosome
• Hybrid Exosome

Exosome Therapeutics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Metabolic Disorders
• Oncology
• Cardiac Disorders
• Neurology
• Inflammatory Disorders
• Organ Transplantation
• Gynecology Disorders
• Blood Disorders
• Others

Exosome Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Research & Academic Institutes
• Hospitals & Diagnostic Centers

Exosome Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Exosome Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies exosome therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the exosome therapeutics companies profiled in this report include-

• Church & Dwight
• GSK
• Pfizer
• Sun Pharmaceutical
• Takeda Pharmaceutical
• F. Hoffmann-La Roche
• Celgene Corporation

Exosome Therapeutics Market Insights

Lucintel forecasts that natural exosome will remain the largest segment over the forecast period due to as more abundant, easier to produce, more biocompatible, and have a longer shelf life than hybrid exosomes.

Within this market, research and academic institutes is expected to remain the larger segment due to high demand for exosome therapeutics research.

North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Features of the Global Exosome Therapeutics Market

Market Size Estimates: Exosome therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Exosome therapeutics market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Exosome therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the exosome therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the exosome therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the exosome therapeutics market size?

Answer: The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030.

Q.2 What is the growth forecast for exosome therapeutics market?

Answer: The global exosome therapeutics market is expected to grow with a CAGR of 25.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the exosome therapeutics market?

Answer: The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

Q4. What are the major segments for exosome therapeutics market?

Answer: The future of the exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets.

Q5. Who are the key exosome therapeutics market companies?

Answer: Some of the key exosome therapeutics companies are as follows:

• Church & Dwight
• GSK
• Pfizer
• Sun Pharmaceutical
• Takeda Pharmaceutical
• F. Hoffmann-La Roche
• Celgene Corporation

Q6. Which exosome therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that natural exosome will remain the larger segment over the forecast period as it is abundant in nature, more biocompatible, and possess a longer shelf life than hybrid exosomes.

Q7. In exosome therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the exosome therapeutics market by type (natural exosome and hybrid exosome), application (metabolic disorders, oncology, cardiac disorders, neurology, inflammatory disorders, organ transplantation, gynecology disorders, blood disorders, and others), end use (research & academic institutes and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Exosome Therapeutics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Exosome Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Exosome Therapeutics Market by Type
  • 3.3.1: Natural Exosome
  • 3.3.2: Hybrid Exosome
• 3.4: Global Exosome Therapeutics Market by Application
  • 3.4.1: Metabolic Disorders
  • 3.4.2: Oncology
  • 3.4.3: Cardiac Disorders
  • 3.4.4: Neurology
  • 3.4.5: Inflammatory Disorders
  • 3.4.6: Organ Transplantation
  • 3.4.7: Gynecology Disorders
  • 3.4.8: Blood Disorders
  • 3.4.9: Others
• 3.5: Global Exosome Therapeutics Market by End Use
  • 3.5.1: Research & Academic Institutes
  • 3.5.2: Hospitals & Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Exosome Therapeutics Market by Region
• 4.2: North American Exosome Therapeutics Market
  • 4.2.2: North American Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
• 4.3: European Exosome Therapeutics Market
  • 4.3.1: European Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
  • 4.3.2: European Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
• 4.4: APAC Exosome Therapeutics Market
  • 4.4.1: APAC Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
  • 4.4.2: APAC Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
• 4.5: ROW Exosome Therapeutics Market
  • 4.5.1: ROW Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
  • 4.5.2: ROW Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Exosome Therapeutics Market by Type
  • 6.1.2: Growth Opportunities for the Global Exosome Therapeutics Market by Application
  • 6.1.3: Growth Opportunities for the Global Exosome Therapeutics Market by End Use
  • 6.1.4: Growth Opportunities for the Global Exosome Therapeutics Market by Region
• 6.2: Emerging Trends in the Global Exosome Therapeutics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Exosome Therapeutics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Therapeutics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Church & Dwight
• 7.2: GSK
• 7.3: Pfizer
• 7.4: Sun Pharmaceutical
• 7.5: Takeda Pharmaceutical
• 7.6: F. Hoffmann-La Roche
• 7.7: CELGENE Corporation